Long COVID continues to affect millions worldwide, yet there are no tangible solutions to address this emerging disease. According to the World Health Organization (WHO), the post-COVID-19 condition, commonly referred to as long COVID occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually three months from the onset of COVID-19, with symptoms that last for at least two months and cannot be explained by an alternative diagnosis.
It is now estimated that between 10-30 per cent that have been infected with COVID-19 are experiencing dozens of unrelenting symptoms including but not limited to fatigue, brain fog and physical aches and pains. These lingering symptoms are reducing their quality of life and their ability to function at home, at work and/or socially. Furthermore, it is important to note that long COVID does not just affect those who were extremely ill with the coronavirus; some COVID-19 patients who have never had a serious illness are now dealing with chronic symptoms.
Long COVID does not just affect those who were extremely ill.
The medical profession does not yet fully understand what is causing these symptoms, and there has been a host of names suggested to describe it – long COVID, post-COVID syndrome, post-acute sequelae of COVID and long-haulers syndrome. Even though there are many symptoms associated with this syndrome, brain fog and fatigue are two of the most common and impairing symptoms.
Although COVID-19 has the capacity to infect anyone, research has identified risk factors pertaining to the development of long COVID. A gradient increase in age, female sex, hospital admission during acute COVID-19, symptom load and the presence of comorbidities like asthma is associated with a higher risk of developing long COVID. Thus, the post-COVID-19 condition is exceptionally prevalent among the older female population, individuals who developed severe pneumonia, showed signs of respiratory distress or required life-sustaining treatment, and those with pre-existing comorbidities. Additionally, recovery for individuals with multiple COVID-19 infections is further exacerbated by the persistent and gruelling symptoms of long COVID.
Long-haulers often are unsure how to handle their lingering symptoms since many organ systems are involved. After the resolution of the acute phase, many individuals find themselves suffering from a long list of difficulties – now exceeding 200 symptoms, says Roger McIntyre, psychiatry and pharmacology professor at the University of Toronto and executive director at Brain & Cognition Discovery Foundation.
An innovative study is underway that aims to help reduce and eliminate brain fog and fatigue in those experiencing long COVID. This study also aims to improve people’s day-to-day function and quality of life.
If you have been infected with COVID and are experiencing lingering symptoms, you might be a candidate for this study. Details can be obtained at www.bcdfoundation.ca. If you are interested in hearing more about your eligibility, please contact email@example.com. The study is open to persons 18 years of age or older who live in Canada.